Flourish Research
- Company typePrivate
- Founded-
- HeadquartersNew York, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
Flourish Research firmographics
Firmographics- Name
- Flourish Research
- Legal name
- Flourish Research LLC
- Website
- https://flourishresearch.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Flourish Research industry classification
Industry- Product category
- Clinical Trial Site Network Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Investigator & Site Training / GCP Support (HLAGACAF)
Keywords
Where Flourish Research is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices31 records
Markets served
Flourish Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Services: Flourish Research generates revenue by conducting Phase I-IV clinical trials for pharmaceutical sponsors and CROs. Services include patient recruitment, study execution, data collection, and regulatory support across their network of wholly-owned research sites.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
Flourish Research product offering
Product offeringCore offering
Flourish Research operates a network of 30+ wholly-owned clinical trial sites across the United States that conducts Phase I-IV clinical trials for pharmaceutical sponsors and CROs. Service offerings span in-patient and outpatient studies, dedicated early-phase/First-in-Human units, in-house PBMC processing, advanced imaging, and therapeutic specialization in cardiometabolic, oncology, neuroscience, and infectious diseases. The network provides patient recruitment, study execution, data collection, and regulatory support through standardized operations and integrated technology platforms.
Product overview
Flourish Research is an industry-leading wholly-owned clinical trial site network offering end-to-end clinical research solutions. The platform operates as a unified network with multiple integrated service modules including Phase I/early phase services with dedicated in-patient units, specialized PBMC processing labs, and advanced imaging services through a GE HealthCare partnership. The network provides therapeutic specializations in cardiometabolic, oncology, neuroscience, and infectious diseases, with sites across Alabama, California, Florida, Georgia, Illinois, Louisiana, Maryland, Michigan, North Carolina, Pennsylvania, and Texas. The company has grown through strategic acquisitions including Valkyrie Clinical Trials (oncology), Merritt Island Medical Research (neuroscience), AMC Research (Alzheimer's), and Diablo Clinical Research (infectious disease).
Differentiator
Problem solved
Functional benefit
Brands
- Flourish Imaging: Advanced imaging center partnership with Capitol Imaging Services, featuring GE HealthCare Omni PET scanner for oncology and CNS clinical trials
- Valkyrie
Quantifiable outcome
- 97% patient retention rate at Boca Raton location for complex cardiovascular trials
- +4 more outcomes
Companies that use Flourish Research
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Flourish Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Flourish Research partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Capitol Imaging ServicescoreFlourish Research partnered with Capitol Imaging Services to launch Flourish Imaging, an advanced imaging center in Gainesville, Georgia. The facility features a GE HealthCare Omni PET scanner supporting both clinical research and community diagnostic imaging with focus on oncology and central nervous system trials. Companies anticipate broader expansion across the Southeast.
- Diablo Clinical ResearchminorIn February 2025, Flourish Research LLC acquired Diablo Clinical Research LLC to expand its geographic and therapeutic scope in the infectious disease clinical trials sector.
- AMC ResearchcoreAcquired in June 2023, AMC Research in Charlotte, North Carolina specializes in Alzheimer's Disease research, enhancing Flourish's neuroscience research capabilities and market reach.
- Central Research Associates (CRA)coreAcquired in June 2023, Central Research Associates in Birmingham, Alabama is a multi-therapeutic site that enhances Flourish's research capabilities and provides access to new markets.
- Merritt Island Medical Research (MIMR)coreAcquired in December 2023, MIMR is a neuroscience clinical research site in Florida that continues its leadership roles while benefiting from Flourish's growth support and expanded research capabilities.
- Center for Advanced Research & Education (CARE)coreAcquired in May 2025, CARE is a healthcare research facility in Gainesville, GA that has conducted over 150 clinical trials. The acquisition expands Flourish's geographic footprint in the Southeast and strengthens pharmaceutical client relationships.
- Valkyrie Clinical TrialscoreIn 2025, Valkyrie Clinical Trials joined the Flourish Research family, bringing deep oncology experience with three locations across Southern California (Century City, Panorama City, and Murrieta). Specializes in early-phase oncology trials and high-risk immunotherapy monitoring with ICU access.
- Center for Haitian StudiesminorFlourish Research North Miami partners with the Center for Haitian Studies, a trusted community resource since 1989, to serve underrepresented populations in research and reduce health disparities.
Scale indicators10 records
Recent moves4 records
Expansion highlights6 records
Flourish Research competitors and assessment
Company assessmentDirect peers
- Velocity Clinical Research: Velocity is a leading integrated site organization also built via the roll-up of wholly-owned clinical trial sites across the U.S., offering Phase II-IV trials to pharma sponsors. It is the closest direct competitor to Flourish's network model, therapeutic-area breadth, and acquisition-driven growth strategy.
- CenExel Clinical Research: CenExel operates a network of wholly-owned clinical research sites specializing in early-phase and CNS trials, including in-patient units similar to Flourish's. It is a direct peer in therapeutic-area focus (neuroscience, cardiometabolic) and early-phase infrastructure.
- Accelerated Enrollment Solutions (AES) / PPD: AES was PPD's dedicated site network for patient enrollment and is the site-network business where Flourish CEO Reinhold Schulz previously served as VP Global Site Network. It remains a direct competitor in dedicated site solutions for pharma sponsors.
Broad incumbents
- WCG (WIRB-Copernicus Group): WCG is a clinical trial services company offering central IRB, technology, and site-support services to sponsors and CROs. As a broader incumbent in the clinical trial services stack, WCG competes for sponsor relationships and is the destination of Flourish's former CFO.
- IQVIA: IQVIA is the largest CRO globally with embedded site networks, technology platforms, and real-world data capabilities. As a broad incumbent, it competes with Flourish both directly (own site footprint) and indirectly (full-service CRO bundling).
- ICON plc: ICON is one of the largest global CROs offering full-service clinical development including site management. It competes for the same pharmaceutical sponsor contracts and can bundle site services as part of larger CRO engagements.
- Medpace Holdings: Medpace is a mid-to-large full-service CRO with embedded site operations that competes for pharmaceutical sponsor trial execution work. Its therapeutically-focused operating model is conceptually adjacent to Flourish's specialist-site positioning.
- Syneos Health (now private): Syneos Health is a large CRO/SMO combination (now owned by Elliott/Veritas/Patient Square) that offers both full-service CRO and dedicated site solutions. It is a broad incumbent competitor with a wholly-owned site network similar to Flourish's.
- PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher, is a top-3 global CRO offering full-service clinical development with embedded site management. It directly overlaps with Flourish on sponsor relationships and site network services.
Emerging players
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO with focused therapeutic expertise (including neuroscience and cardiometabolic) that competes with Flourish on mid-sized pharma trial execution. It is a smaller-scale peer to the top global CROs but a meaningful emerging competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Flourish Research social profiles
Digital presenceFlourish Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Flourish Research leadership team
Management profileNumber of profiles
Profiles8 records
Flourish Research subsidiaries and ownership
Company hierarchySubsidiaries7 records
Flourish Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Flourish Research M&A and investment
M&A and investmentM&A5 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Flourish Research
What does Flourish Research do?
Flourish Research operates a network of 30+ wholly-owned clinical trial sites across the United States that conducts Phase I-IV clinical trials for pharmaceutical sponsors and CROs. Service offerings span in-patient and outpatient studies, dedicated early-phase/First-in-Human units, in-house PBMC processing, advanced imaging, and therapeutic specialization in cardiometabolic, oncology, neuroscience, and infectious diseases. The network provides patient recruitment, study execution, data collection, and regulatory support through standardized operations and integrated technology platforms.
Is Flourish Research a public or private company?
Flourish Research is a private company. It is classified as private equity controlled and is currently operating.
When was Flourish Research founded?
Flourish Research was founded in -1. It employs 501 to 1,000 people.
Where is Flourish Research based?
Flourish Research is headquartered in New York, United States, in the North America region.
How does Flourish Research make money?
One revenue line is on record: clinical Trial Services.
Who are Flourish Research's main competitors?
Direct peers on record are Velocity Clinical Research, CenExel Clinical Research and Accelerated Enrollment Solutions (AES) / PPD. Broad incumbents are WCG (WIRB-Copernicus Group), IQVIA, ICON plc, Medpace Holdings, Syneos Health (now private) and PPD (Thermo Fisher Scientific). Worldwide Clinical Trials is listed as an emerging player.
Does Flourish Research have an API?
No public API is recorded for Flourish Research.
What industry is Flourish Research in?
Flourish Research's product category is Clinical Trial Site Network Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAC, Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts). Its NAICS code is 5417 and its SIC code is 8731.